LICORDARI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 539
NA - Nord America 520
AS - Asia 83
SA - Sud America 11
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.155
Nazione #
US - Stati Uniti d'America 519
IE - Irlanda 224
SE - Svezia 130
IT - Italia 127
SG - Singapore 34
IN - India 27
FI - Finlandia 17
CN - Cina 16
AT - Austria 13
DE - Germania 12
GB - Regno Unito 6
HK - Hong Kong 6
CL - Cile 5
BR - Brasile 4
BE - Belgio 3
CZ - Repubblica Ceca 2
FR - Francia 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CA - Canada 1
CO - Colombia 1
MA - Marocco 1
NL - Olanda 1
Totale 1.155
Città #
Dublin 224
Chandler 117
Ashburn 93
Nyköping 80
New York 46
Messina 22
Singapore 21
Pune 20
Princeton 19
Medford 18
Helsinki 15
Vienna 13
Catania 11
Los Angeles 10
Boardman 8
Des Moines 8
Munich 7
Hyderabad 6
London 6
Bremen 5
Chicago 5
Rome 5
Petrosino 4
Porto Alegre 4
Seattle 4
Beijing 3
Bologna 3
Brussels 3
Citta 3
Florence 3
Gravina di Catania 3
Milan 3
Nanchang 3
Sciacca 3
Washington 3
Zumpano 3
Bisignano 2
Gela 2
Guangzhou 2
Lappeenranta 2
Palermo 2
Redwood City 2
Turin 2
Wilmington 2
Albuquerque 1
Belvedere Spinello 1
Bogotá 1
Brno 1
Castelnuovo Rangone 1
Fuzhou 1
Jinan 1
Lanzhou 1
Lyon 1
Meppel 1
Montecorice 1
Olomouc 1
Piazza Armerina 1
Puerto Eldorado 1
Santa Clara 1
Santa Venerina 1
Shenyang 1
Springfield 1
Strasbourg 1
Taiyuan 1
Tianjin 1
Zhengzhou 1
Totale 842
Nome #
Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case 88
Comparison of new myocardial work indexes and others left ventricle sistolic function parameters in ischaemic patients 76
Takotsubo syndrome: prognostic predictors 61
Analysis of multilayer strain and myocardial work in patients undergoing chemotherapy treatment: a 12 months follow-up 57
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 57
Ruolo dell'intervello PPI post ATP fallito nella discriminazione degli ICD 52
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 51
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 47
Bicuspid aortic valve and aortopathy: novel prognostic predictors for the identification of high-risk patients 45
Cardiac and Vascular Impairment in Patients with Mild Psoriasis: A Longitudinal Study 45
Non-invasive assessment of myocardial work: an useful tool for predicting LV remodelling after myocardial infarction? 42
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 42
An “ordinary” case of COVID-19 pneumonia: when symptoms hide serious complications 40
Prognostic value of two-dimensional strain in early ischemic heart disease: A 5-year follow-up study 32
Early impairment of right ventricular morphology and function in transthyretin-related cardiac amyloidosis 31
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 30
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 29
62 MYOCARDIAL WORK IN CARDIAC AMYLOIDOSIS AND HYPERTENSIVE HEART DISEASE: A PRELIMINARY REPORT 25
DAPAGLIFOZIN AND PULMONARY PRESSURES IN HFREF: A NON INVASIVE ASSESSMENT 24
QTC CORRECTION IN ATRIAL FIBRILLATION 23
Echocardiographic Patterns of Abnormal Septal Motion: Beyond Myocardial Ischemia 23
Assessment of Intra and Extra-Hospital Outcome after Takotsubo Syndrome in a Single-Center Population 23
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 23
PROGNOSTIC VALUE OF TWO DIMENSIONAL STRAIN IN EARLY ISCHEMIC HEART DISEASE: A 5-YEAR FOLLOW-UP STUDY 22
SCREENING FOR ANDERSON-FABRY DISEASE IN RELATIVELY YOUNG PATIENTS WITH UNEXPLAINED CONDUCTION DISORDERS REQUIRING PACEMAKER IMPLANTATION 22
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 22
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 21
Lipomatous Hypertrophy of the Interatrial Septum: A Case Report and Insights from the Literature 20
The High Bleeding Risk Patient with Coronary Artery Disease 19
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 16
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 15
Atrial Fibrillation and QT corrected. What is the best formula to use? 14
null 13
Advanced echocardiographic analysis to identify cardiac toxicity after TKI exposure in patients with CML 13
Anthracyclines therapy and regional myocardial damage in breast cancer patients: how, when and where? 10
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 10
Incidence of acute myocarditis and pericarditis during the coronavirus disease 2019 pandemic: comparison with the prepandemic period 8
Multimodality imaging to assess severity and outcome in asymptomatic patients with aortic stenosis: a medium-long term follow-up study 8
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population 6
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 3
Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers 3
RISK STRATIFICATION AND PREDICTORS OF OUTCOME IN ASYMPTOMATIC AORTIC STENOSIS: THE ROLE OF MULTIMODALITY IMAGING 3
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 2
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 2
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance 2
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 2
Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction 2
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 2
Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patients 2
Totale 1.228
Categoria #
all - tutte 7.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 4 0 0
2020/202168 0 0 4 15 11 12 15 4 1 2 4 0
2021/2022144 0 6 11 1 3 1 8 5 8 46 1 54
2022/2023605 28 51 18 25 26 83 16 44 270 11 23 10
2023/2024350 15 38 9 34 29 106 53 17 5 13 2 29
2024/202557 18 28 11 0 0 0 0 0 0 0 0 0
Totale 1.228